Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries

International Journal of Antimicrobial Agents

Volumn 16, Issue 1, 2000, Pages 17-24

  Jacobs, Michael R ^a   Appelbaum, Peter C ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

lactam; Latin American and Caribbean countries; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFOTAXIME; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BACTERIUM ISOLATE; BRAZIL; CARIBBEAN ISLANDS; CHILE; MEXICO; MINIMUM INHIBITORY CONCENTRATION; PANAMA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; SOUTH AND CENTRAL AMERICA; STREPTOCOCCUS PNEUMONIAE; VENEZUELA;

ANTI-BACTERIAL AGENTS; CARIBBEAN REGION; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MICROBIAL; HUMANS; INFANT; LACTAMS; LATIN AMERICA; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0033839134     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00193-X     Document Type: Article

References (28)

1. Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity and treatment. Clin. Infect. Dis. 14:1992;801-807.
2. DiFabio J.L., Homma A., DeQuadros C. Pan American health organization epidemiological surveillance network for Streptococcus pneumoniae. Microb. Drug Resistance. 3:1997;131-133.
3. Bolan G., Broome C.V., Facklam R.R., et al. Pneumococcal vaccine efficacy in selected populations in the United States. Ann. Intern. Med. 104:1986;1-6.
4. Appelbaum P.C. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:1992;77-83.
5. Juliet C., Giglio M.S., Camponovo R. Sensibilidad de Streptococcus pneumoniae y su importancia clinica. Rev. Med. Chil. 115:1987;852-857.
6. Rossi A., Ruvinsky R., Regueira M., et al. Distribution of capsular types and penicillin-resistance of strains of Streptococcus pneumoniae causing systemic infections in Argentinian children under 5 years of age. Microb. Drug Resistance. 3:1997;135-140.
7. De Cunto Brandileone M.C., Simonsen Dias Vieira V., Tadeu Casagrande S., et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Microb. Drug Resistance. 3:1997;141-146.
8. Castaneda E., Leal A.L., Castillo O., et al. Distribution of capsular types and antimicrobial susceptibility of invasive isolates of Streptococcus pneumoniae in Columbian children. Microb. Drug Resistance. 3:1997;147-151.
9. Echaniz-Aviles G., Velazquez-Meza M.A., Carnalla-Barajas M.N., et al. Antimicrobial susceptibilities and capsular types of invasive Streptococcus pneumoniae isolated in children in Mexico city. Microb. Drug Resistance. 3:1997;153-157.
10. Hortal M, Pneumococcus Study Group. Capsular type distribution and susceptibility to antibiotics of Streptococcus pneumoniae clinical strains isolated from Uruguayan children with systemic infections, Microb Drug Resistance 1997;3:159-163.
11. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, sixth ed.; Approved Standard. [M2-A6] Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
12. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing, Eighth Informational Supplement. [M100-S8] Wayne, PA: National Committee for Clinical Laboratory Standards, 1998.
13. Craig W.A., Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media. Pediatr. Infect. Dis. J. 15:1996;255-259.
14. Jacobs M.R., Bajaksouzian S., Zilles A., et al. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to oral antimicrobial agents based on pharmacodymanic parameters: U.S. surveillance study. Antimicrob. Agents Chemother. 43:1999;1901-1908.
15. Doern G.V., Pfaller M.A., Kugler K., et al. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: results from the SENTRY antimicrobial surveillance program. Clin. Infect. Dis. 27:1997;764-770.
16. Dagan R., Leibovitz E., Fliss D.M., Leiberman A., Jacobs M.R., Craig W., Yagupsky P. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob. Agents Chemother. 44:2000;43-50.
17. Dagan R., Johnson C.E., McLinn S., Abughali N., Feris J., Leibovitz E., Burch D.J., Jacobs M.R. Bacteriologic and clinical efficacy of amoxycillin/clavulanate versus azithromycin in acute otitis media. Pediatr. Infect. Dis. J. 19:2000;95-104.
18. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. [M100-S10] Wayne, PA: National Committee for Clinical Laboratory Standards, 2000.
19. Mogdasy M.C., Camou T., Fajardo C., Hortal M. Colonizing and invasive strains of S. pneumoniae in Uruguayan children: type distribution and patterns of antibiotic resistance. Pediatr. Infect. Dis. J. 11:1992;648-652.
20. Dowell S.F., Whitney C.G., Schwartz B. Regional characteristics of drug-resistant respiratory pathogens. Am. J. Med. Continuing Educ. Ser. 2:1997;9-16.
21. Zenni M.K., Cheatham S.H., Thompson J.M., et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J. Pediatr. 127:1995;533-537.
22. Nava J.M., Bella F., Garau J., et al. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis. 19:1994;884-890.
23. Reichler M.R., Allphin A.A., Breiman R.F., et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J. Infect. Dis. 166:1992;1346-1353.
24. Dowell S.F., Butler J.C., Giebink G.S., et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group (DRSPTWG). Pediatr. Infect. Dis. J. 18:1999;1-9.
25. McCracken G.H., Nelson J.D., Kaplan S.L., et al. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr. Infect. Dis. J. 6:1987;501-505.
26. McCracken G.H., Sakata Y. Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae with different susceptibilities to penicillin. Antimicrob. Agents Chemother. 27:1985;141-145.
27. Lopes E, Meropenem Study Group. Meropenem versus cefotaxime or ceftriaxone for bacterial meningitis [abstract 638]. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1993. p. 236.
28. Pallares R., Gudiol F., Linares J., et al. Risk factors and response to antibiotic therapy in adults with Bacteremic pneumoniae caused by penicillin-resistant pneumococci. New Engl. J. Med. 317:1987;18-22.